PMID- 20570963 OWN - NLM STAT- MEDLINE DCOM- 20101221 LR - 20220310 IS - 1530-6860 (Electronic) IS - 0892-6638 (Print) IS - 0892-6638 (Linking) VI - 24 IP - 11 DP - 2010 Nov TI - FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis. PG - 4240-9 LID - 10.1096/fj.10-159913 [doi] AB - Lipoxins (LXs) are endogenously produced eicosanoids with well-described anti-inflammatory and proresolution activities, stimulating nonphlogistic phagocytosis of apoptotic cells by macrophages. LXA(4) and the glucocorticoid-derived annexin A1 peptide (Ac2-26) bind to a common G-protein-coupled receptor, termed FPR2/ALX. However, direct evidence of the involvement of FPR2/ALX in the anti-inflammatory and proresolution activity of LXA(4) is still to be investigated. Here we describe FPR2/ALX trafficking in response to LXA(4) and Ac2-26 stimulation. We have transfected cells with HA-tagged FPR2/ALX and studied receptor trafficking in unstimulated, LXA(4) (1-10 nM)- and Ac2-26 (30 muM)-treated cells using multiple approaches that include immunofluorescent confocal microscopy, immunogold labeling of cryosections, and ELISA and investigated receptor trafficking in agonist-stimulated phagocytosis. We conclude that PKC-dependent internalization of FPR2/ALX is required for phagocytosis. Using bone marrow-derived macrophages (BMDMs) from mice in which the FPR2/ALX ortholog Fpr2 had been deleted, we observed the nonredundant function for this receptor in LXA(4) and Ac2-26 stimulated phagocytosis of apoptotic neutrophils. LXA(4) stimulated phagocytosis 1.7-fold above basal (P<0.001) by BMDMs from wild-type mice, whereas no effect was found on BMDMs from Fpr2(-/-) mice. Similarly, Ac2-26 stimulates phagocytosis by BMDMs from wild-type mice 1.5-fold above basal (P<0.05). However, Ac2-26 failed to stimulate phagocytosis by BMDMs isolated from Fpr2(-/-) mice relative to vehicle. These data reveal novel and complex mechanisms of the FPR2/ALX receptor trafficking and functionality in the resolution of inflammation. FAU - Maderna, Paola AU - Maderna P AD - UCD Diabetes Research Centre, UCD School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. FAU - Cottell, David C AU - Cottell DC FAU - Toivonen, Tiina AU - Toivonen T FAU - Dufton, Neil AU - Dufton N FAU - Dalli, Jesmond AU - Dalli J FAU - Perretti, Mauro AU - Perretti M FAU - Godson, Catherine AU - Godson C LA - eng GR - 086867/WT_/Wellcome Trust/United Kingdom GR - 086867/Z/08/WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100622 PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Annexins) RN - 0 (FPR2 protein, human) RN - 0 (Lipoxins) RN - 0 (Peptides) RN - 0 (Receptors, Formyl Peptide) RN - 0 (Receptors, Lipoxin) RN - 0 (lipoxin A4) SB - IM MH - Animals MH - Annexins/*pharmacology MH - Gene Expression Regulation/drug effects MH - HeLa Cells MH - Humans MH - Lipoxins/*pharmacology MH - Mice MH - Microscopy, Confocal MH - Peptides/*pharmacology MH - Phagocytosis/drug effects MH - Protein Transport/drug effects MH - Receptors, Formyl Peptide/genetics/*metabolism MH - Receptors, Lipoxin/genetics/*metabolism PMC - PMC4338542 MID - EMS61327 OID - NLM: EMS61327 EDAT- 2010/06/24 06:00 MHDA- 2010/12/22 06:00 PMCR- 2015/02/24 CRDT- 2010/06/24 06:00 PHST- 2010/06/24 06:00 [entrez] PHST- 2010/06/24 06:00 [pubmed] PHST- 2010/12/22 06:00 [medline] PHST- 2015/02/24 00:00 [pmc-release] AID - fj.10-159913 [pii] AID - 10.1096/fj.10-159913 [doi] PST - ppublish SO - FASEB J. 2010 Nov;24(11):4240-9. doi: 10.1096/fj.10-159913. Epub 2010 Jun 22.